Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness.
D000086:Acetazolamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000138:Acidosis / Q000209:etiology; D000328:Adult; D002648:Child; D004573:Electrolytes / Q000097:blood; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010245:Paralyses, Familial Periodic / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D010919:Placebos; D011188:Potassium / Q000378:metabolism; D011189:Potassium Chloride / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D004573:Electrolytes; D010919:Placebos; D013148:Spironolactone; D011189:Potassium Chloride; D000086:Acetazolamide; D011188:Potassium